GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win

GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win
aliu
Fri, 11/12/2021 – 11:43